Skip to main content

Baxter International Inc

BAX
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000010456

No open-market purchases or sales by Baxter International Inc insiders were filed in the last 90 days; 689 institutions reported holding it in 13F filings for Q2 2026, worth $11.9B in total; Greenhaven Associates is the only superinvestor holding it.

Superinvestors holding BAX, Q2 2026

1 superinvestor reports holding Baxter International Inc on Form 13F, worth $304.6M in total. Weight is Baxter International Inc's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding BAX in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Greenhaven AssociatesEdgar Wachenheim III3.5%14,285,228$304.6MReduced−0.2%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BAX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Reduced
    Greenhaven Associates (−0.2%)
  2. Q1 2026

    1 superinvestor holding at quarter end

    Added
    Greenhaven Associates (+33.8%)
    Sold out
    Harris Associates (Oakmark)
  3. Q4 2025

    2 superinvestors holding at quarter end

    Added
    Greenhaven Associates (+70.0%)
    Reduced
    Harris Associates (Oakmark) (−0.3%)
  4. Q3 2025

    2 superinvestors holding at quarter end

    New
    Greenhaven Associates
    Reduced
    Harris Associates (Oakmark) (−9.4%)
  5. Q2 2025

    1 superinvestor holding at quarter end

    Added
    Harris Associates (Oakmark) (+3.8%)
  6. Q1 2025

    1 superinvestor holding at quarter end

    Added
    Harris Associates (Oakmark) (+6.4%)
  7. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−13.4%)
  8. Q3 2024

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−5.3%)
  9. Q2 2024

    1 superinvestor holding at quarter end

    Added
    Harris Associates (Oakmark) (+3.6%)
    Sold out
    Maverick Capital
  10. Q1 2024

    2 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+7.8%)
    Reduced
    Maverick Capital (−2.6%)
  11. Q4 2023

    2 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+20.5%)
    Reduced
    Maverick Capital (−2.0%)
  12. Q3 2023

    2 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+216.6%)
    Reduced
    Maverick Capital (−19.8%)
  13. Q2 2023

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Added
    Harris Associates (Oakmark) (+15,911.7%)
  14. Q1 2023

    1 superinvestor holding at quarter end

    Added
    Harris Associates (Oakmark) (+73.1%)
  15. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−3.3%)
    Sold out
    Maverick Capital
  16. Q3 2022

    2 superinvestors holding at quarter end

    New
    Maverick Capital
  17. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−12.5%)
  18. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−39.7%)
  19. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−34.7%)
    Sold out
    Maverick Capital
  20. Q3 2021

    2 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+2.7%), Maverick Capital (+440.9%)
  21. Q2 2021

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Harris Associates (Oakmark) (−11.0%)
    Sold out
    D1 Capital Partners